These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3904380)

  • 1. Mexiletine: double-blind comparison with procainamide in PVC suppression and open-label sequential comparison with amiodarone in life-threatening ventricular arrhythmias.
    Nademanee K; Feld G; Hendrickson J; Intarachot V; Yale C; Heng MK; Singh BN
    Am Heart J; 1985 Nov; 110(5):923-31. PubMed ID: 3904380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias].
    Purcaro A; Massacci C; Curzi G; Pigini G; Costantini C; Bilancini A; Blandini A
    G Ital Cardiol; 1986 May; 16(5):417-26. PubMed ID: 3732727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined mexiletine and amiodarone treatment of refractory recurrent ventricular tachycardia.
    Waleffe A; Mary-Rabine L; Legrand V; Demoulin JC; Kulbertus HE
    Am Heart J; 1980 Dec; 100(6 Pt 1):788-93. PubMed ID: 7446381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative antiarrhythmic efficacy of verapamil, 17-monochloracetylajmaline, mexiletine and amiodarone in patients with severe chagasic myocarditis: relation with the underlying arrhythmogenic mechanisms.
    Haedo AH; Chiale PA; Bandieri JD; Lázzari JO; Elizari MV; Rosenbaum MB
    J Am Coll Cardiol; 1986 May; 7(5):1114-20. PubMed ID: 3958370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of procainamide and mexiletine in prevention of ventricular arrhythmias after acute myocardial infarction.
    Campbell RW; Dolder MA; Prescott LF; Talbot RG; Murray A; Julian DG
    Lancet; 1975 Jun; 1(7919):1257-60. PubMed ID: 48894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of mexiletine in the medium-term treatment of ventricular arrhythmias. A randomized, double-blind, crossover trial against placebo in ambulatory patients.
    Masotti G; Morettini A; Casolo GC; Ieri A; Zipoli A; Serneri GG
    J Int Med Res; 1984; 12(2):73-80. PubMed ID: 6202571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Monitoring of anti-arrhythmia drugs with the Holter system and the determination of their blood levels (mexiletine (mexitil) and amiodarone)].
    Paciaroni E; Ferroni C; Marini M; Campanari G
    Minerva Cardioangiol; 1985 May; 33(5):251-8. PubMed ID: 4033966
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative anti-arrhythmic efficacy of mexiletine, procainamide and tolamolol in patients with symptomatic ventricular arrhythmias.
    Jewitt DE; Jackson G; McComish M
    Postgrad Med J; 1977; 53 Suppl 1():158-62. PubMed ID: 327454
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of ventricular arrhythmias after acute myocardial infarct with procaine amide and mexiletine].
    Dolder M; Campbell RW; Talbot RG; Murray A; Prescott LE; Julian DG
    Adv Clin Pharmacol; 1978; 16():59-70. PubMed ID: 356554
    [No Abstract]   [Full Text] [Related]  

  • 10. Intolerance and ineffectiveness of mexiletine in patients with serious ventricular arrhythmias.
    Poole JE; Werner JA; Bardy GH; Graham EL; Pulaski WP; Fahrenbruch CE; Greene HL
    Am Heart J; 1986 Aug; 112(2):322-6. PubMed ID: 3739884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mexiletine. Use in control of chronic drug-resistant ventricular arrhythmia.
    Abinader EG; Cooper M
    JAMA; 1979 Jul; 242(4):337-9. PubMed ID: 448936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of mexiletine in chronic ventricular arrhythmias compared with quinidine: a single-blind, randomized trial.
    Singh JB; Rasul AM; Shah A; Adams E; Flessas A; Kocot SL
    Am J Cardiol; 1984 Jan; 53(1):84-7. PubMed ID: 6362388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Well-controlled comparative study of the clinical effectiveness of intravenous mexiletine and procainamide on ventricular premature contraction.
    Arakawa K; Doi Y; Hashiba K; Mitsuoka T; Yanaga T; Hata Y; Ogawa N
    Jpn Heart J; 1984 May; 25(3):357-77. PubMed ID: 6206252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term mexiletine for ventricular arrhythmia.
    Stein J; Podrid PJ; Lampert S; Hirsowitz G; Lown B
    Am Heart J; 1984 May; 107(5 Pt 2):1091-8. PubMed ID: 6720534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular arrhythmias after acute myocardial infarction treated with procainamide or mexiletine.
    Campbell RW; Dolder MA; Prescott LF; Talbot RG; Murray A; Julian DG
    Postgrad Med J; 1977; 53 Suppl 1():150-3. PubMed ID: 327453
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative cost-effectiveness analysis of quinidine, procainamide and mexiletine.
    Podrid PJ; Kowey PR; Frishman WH; Arnold RJ; Kaniecki DJ; Beck JR; Beshansky JR
    Am J Cardiol; 1991 Dec; 68(17):1662-7. PubMed ID: 1836102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of oral mexiletine therapy in the treatment of ventricular arrhythmias.
    Rutledge JC; Harris F; Amsterdam EA
    J Am Coll Cardiol; 1985 Oct; 6(4):780-4. PubMed ID: 4031292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mexiletine for refractory-ventricular arrhythmias: results using serial electrophysiologic testing.
    DiMarco JP; Garan H; Ruskin JN
    Am J Cardiol; 1981 Jan; 47(1):131-8. PubMed ID: 7457398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of oral mexiletine in the prevention of exercise-induced ventricular ectopic activity.
    Koch G; Lindström B
    Eur J Clin Pharmacol; 1978 Jun; 13(4):237-40. PubMed ID: 352705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mexiletine and quinidine in ventricular ectopy.
    Fenster PE; Hanson CD
    Clin Pharmacol Ther; 1983 Aug; 34(2):136-42. PubMed ID: 6347497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.